Symbol="ADMP"
AssetType="Common Stock"
Name="Adamis Pharma"
Description="Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California."
CIK="887247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5724700"
EBITDA="-22324544"
PERatio="None"
PEGRatio="0"
BookValue="-4.071"
DividendPerShare="0"
DividendYield="0"
EPS="-10.08"
RevenuePerShareTTM="2.348"
ProfitMargin="0"
OperatingMarginTTM="-4.664"
ReturnOnAssetsTTM="-0.744"
ReturnOnEquityTTM="-7.85"
RevenueTTM="5054600"
GrossProfitTTM="-1431408"
DilutedEPSTTM="-10.08"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.259"
AnalystTargetPrice="0.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="8.62"
EVToRevenue="15.59"
EVToEBITDA="-0.784"
Beta="1.259"
num_52WeekHigh="36.98"
num_52WeekLow="1.9"
num_50DayMovingAverage="3.299"
num_200DayMovingAverage="9.9"
SharesOutstanding="2662600"
DividendDate="None"
ExDividendDate="None"
symbol="ADMP"
open="2.11"
high="2.16"
low="2.06"
price="2.15"
volume="33136.00"
latest_trading_day="2023-07-07"
previous_close="2.09"
change="0.06"
change_percent="2.8708%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="82"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="1333502"
Change_recent_avg="-0.02"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-2.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="1136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_negative_thumbnail_id_2="1133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
